3/17
04:40 pm
agen
Agenus Announces Upcoming AACR 2026 Presentation Evaluating Botensilimab Plus Balstilimab in First-Line MSS Metastatic Colorectal Cancer
Medium
Report
Agenus Announces Upcoming AACR 2026 Presentation Evaluating Botensilimab Plus Balstilimab in First-Line MSS Metastatic Colorectal Cancer
3/16
08:06 am
agen
Agenus Reports 2025 Results; BOT+BAL Advances to Phase 3 and Early Access Programs Expand Globally with Initial Revenues Recognized [Yahoo! Finance]
Medium
Report
Agenus Reports 2025 Results; BOT+BAL Advances to Phase 3 and Early Access Programs Expand Globally with Initial Revenues Recognized [Yahoo! Finance]
3/16
07:30 am
agen
Agenus Reports 2025 Results; BOT+BAL Advances to Phase 3 and Early Access Programs Expand Globally with Initial Revenues Recognized
Medium
Report
Agenus Reports 2025 Results; BOT+BAL Advances to Phase 3 and Early Access Programs Expand Globally with Initial Revenues Recognized
3/10
08:11 am
agen
Agenus receives $20M payment under Zydus Life Sciences collaboration [Seeking Alpha]
Medium
Report
Agenus receives $20M payment under Zydus Life Sciences collaboration [Seeking Alpha]
3/10
07:47 am
agen
Agenus Triggers First $20M Contingent Payment Under Zydus Life Sciences Collaboration to Support BOT+BAL Manufacturing Needs [Yahoo! Finance]
Medium
Report
Agenus Triggers First $20M Contingent Payment Under Zydus Life Sciences Collaboration to Support BOT+BAL Manufacturing Needs [Yahoo! Finance]
3/10
07:30 am
agen
Agenus Triggers First $20M Contingent Payment Under Zydus Life Sciences Collaboration to Support BOT+BAL Manufacturing Needs
Medium
Report
Agenus Triggers First $20M Contingent Payment Under Zydus Life Sciences Collaboration to Support BOT+BAL Manufacturing Needs
3/4
04:46 pm
agen
Agenus to Provide Fourth Quarter and Year-end 2025 Financial Report and Corporate Update [Yahoo! Finance]
High
Report
Agenus to Provide Fourth Quarter and Year-end 2025 Financial Report and Corporate Update [Yahoo! Finance]
3/4
04:30 pm
agen
Agenus to Provide Fourth Quarter and Year-end 2025 Financial Report and Corporate Update
High
Report
Agenus to Provide Fourth Quarter and Year-end 2025 Financial Report and Corporate Update
11/10/2025
07:30 am
AGEN
agenus inc.
MISS
Report
9.4%
agenus inc.
8/11/2025
07:00 am
AGEN
agenus inc.
MISS
Report
-13.6%
agenus inc.
5/12/2025
07:30 am
AGEN
agenus inc.
BEAT
Report
11.5%
agenus inc.
3/16
05:19 pm
agen
Form 10-K AGENUS INC For: Dec 31
High
Report
Form 10-K AGENUS INC For: Dec 31
3/16
08:15 am
agen
Form 8-K AGENUS INC For: Mar 16
Medium
Report
Form 8-K AGENUS INC For: Mar 16
3/9
04:15 pm
agen
Form 4 AGENUS INC For: Mar 06 Filed by: ARMEN GARO H
Medium
Report
Form 4 AGENUS INC For: Mar 06 Filed by: ARMEN GARO H
2/24
04:05 pm
agen
Form 4 AGENUS INC For: Feb 20 Filed by: ARMEN GARO H
Low
Report
Form 4 AGENUS INC For: Feb 20 Filed by: ARMEN GARO H
2/9
04:05 pm
agen
Form 4 AGENUS INC For: Feb 06 Filed by: ARMEN GARO H
Medium
Report
Form 4 AGENUS INC For: Feb 06 Filed by: ARMEN GARO H
1/26
04:05 pm
agen
Form 4 AGENUS INC For: Jan 23 Filed by: ARMEN GARO H
Medium
Report
Form 4 AGENUS INC For: Jan 23 Filed by: ARMEN GARO H
1/23
08:58 am
agen
Form SCHEDULE 13D AGENUS INC Filed by: ZYNEXT VENTURES USA LLC
Medium
Report
Form SCHEDULE 13D AGENUS INC Filed by: ZYNEXT VENTURES USA LLC
1/16
04:05 pm
agen
Form 3 AGENUS INC For: Jan 08 Filed by: Charette Austin
Low
Report
Form 3 AGENUS INC For: Jan 08 Filed by: Charette Austin
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register